ISDA

Deposition Date 2019-01-10

Release Date 2019-02-20

Last Version Date 2024-11-13

Entry Detail

PDB ID:

6NM7

Keywords:

immune system/inhibitor

Title:

PD-L1 IgV domain bound to fragment

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.43 Å

R-Value Free:

0.26

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

P 21 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Programmed cell death 1 ligand 1
Gene (Uniprot):CD274
Mutations:V76T
Chain IDs:A, B
Chain Length:129
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:Q9NZQ7 Pfam ID:PF07686

Ligand Molecules

22L

Primary Citation

Fragment-based screening of programmed death ligand 1 (PD-L1).

Perry, E, Mills, J.J, Zhao, B, Wang, F, Sun, Q, Christov, P.P, Tarr, J.C, Rietz, T.A, Olejniczak, E.T, Lee, T, Fesik, S.Show

Bioorg. Med. Chem. Lett. 29 786 790 (2019)

PMID: 30728114 DOI: 10.1016/j.bmcl.2019.01.028

Abstact

The PD-1 immune checkpoint pathway is a highly validated target for cancer immunotherapy. Despite the potential advantages of small molecule inhibitors over antibodies, the discovery of small molecule checkpoint inhibitors has lagged behind. To discover small molecule inhibitors of the PD-1 pathway, we have utilized a fragment-based approach. Small molecules were identified that bind to PD-L1 and crystal structures of these compounds bound to PD-L1 were obtained.

Legend

Protein

Chemical

Disease

Primary Citation of related structures